ZBH
ZIMMER BIOMET HOLDINGS, INC.
NYSE · Healthcare · Medical - Devices · US
$95.36
+1.18%Sep 16, 2026, 08:06 UTC
In August 2026, the second-instance ruling in the contract dispute between Guoke Hengtai's wholly-owned subsidiary Guoke Hengmao and Zimmer Biomet and Jiemei Medical dismissed the appeal and upheld the original judgment.
Source:Sep 8, 2026, 20:38 UTC
Zimmer Biomet announced that Kevin Thornal will depart as Group President of Global Businesses and the Americas, effective September 30, 2026, with severance of twelve months' salary and bonus plus COBRA premiums.
Sep 8, 2026, 20:30 UTC
Zimmer Biomet announced leadership promotions in its Americas commercial organization, promoting Gary Campbell to President, Americas; Brian Hatcher to President, Recon, S.E.T., CMFT, Neuro and Biosurgery; and Bradley Kessler to President, Americas – Robotics, Technology and Data.
Source:Sep 3, 2026, 18:45 UTC
Zimmer Biomet will relocate its global headquarters to 1800 W. Center Street in Warsaw, the largest orthopedic manufacturing facility in the world.
Source:Sep 3, 2026, 18:45 UTC
Zimmer Biomet donates its world headquarters building at 345 E. Main Street in Warsaw to Grace College, with ownership transferring in early 2027.
Source:Aug 28, 2026, 20:15 UTC
Zimmer Biomet Holdings announced that its Board of Directors approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2026.
Source:Aug 5, 2026, 19:45 UTC
Zimmer Biomet expects to launch the full market release of its Rosa Shoulder product in the coming weeks.
Source:Aug 5, 2026, 00:00 UTC
Zimmer Biomet Holdings, Inc. reported its second quarter 2026 financial results, with net sales of $2.177 billion, net earnings of $198.3 million, and diluted EPS of $1.03.
Aug 5, 2026, 00:00 UTC
Zimmer Biomet Holdings, Inc. announced a share repurchase program of up to $1 billion for fiscal 2026.
Jul 28, 2026, 16:00 UTC
Zimmer Biomet secured $2.75 billion through two new revolving credit agreements in June 2026.
Source:Jul 28, 2026, 16:00 UTC
Zimmer Biomet signed an agreement to acquire Embody, an orthobiologics company, for $155 million.
Source:Jul 28, 2026, 16:00 UTC
Zimmer Biomet completed its acquisition of Paragon 28, a medical device company in the foot-and-ankle orthopedic sector, for about $1.1 billion.
Source:Jul 28, 2026, 16:00 UTC
Zimmer Biomet entered into a definitive agreement to acquire Monogram Technologies, an orthopedic robotics company, for $177 million.
Source:Jul 21, 2026, 23:59 UTC
Zimmer Biomet filed a federal lawsuit against former executive Kristoff Goson for alleged breach of confidentiality and non-compete agreement and misappropriation of trade secrets.
Source:Jul 14, 2026, 11:00 UTC
Zimmer Biomet Holdings named Chintan Desai as president of its Asia Pacific Region, effective immediately.
Source:Jul 2, 2026, 09:37 UTC
Zimmer Biomet plans to hire 500 employees over three years for its newly opened technology centre in Bengaluru, India.
Source:Jul 1, 2026, 14:30 UTC
Pacira Pharmaceuticals is selling its iovera business to Zimmer Biomet in a deal valued at up to $140 million.
Source:Jul 1, 2026, 00:00 UTC
Omnicell, Inc. appointed Nnamdi Njoku as President and Chief Operating Officer, effective June 2026.
Source: